Stockscreener 앱 받기
1.13
0.00%
0.00
Cocrystal Pharma Inc 주식(COCP)의 최신 뉴스
Cocrystal Pharma Inc (COCP) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Cocrystal Pharma: The Strategic Reset Investors May Be Missing - Yahoo Finance
Cocrystal Pharma Inc. (COCP) Shareholding Pattern – Promoters, FIIs & DIIs - Value Research
Cocrystal (COCP) director Brosgart files with zero reported holdings - Stock Titan
COCP: 5 Million Private Placement with OPKO Health - Smartkarma
Cocrystal (COCP) Q1 2026 Results: The EPS Result Is Below Expectation in the Reported Period; After Earnings: The Share Price Adds 0.87%Dividend Increase Stocks - vinanet.vn
Stock Options: Choosing The Right Viral Inoculum For An Early-Phase Norovirus Trial - Clinical Leader
Cocrystal Pharma appoints Carol L. Brosgart to board of directors By Investing.com - Investing.com South Africa
Form 8K Cocrystal Pharma Inc For: 18 August By Investing.com - Investing.com Nigeria
Cocrystal Pharma appoints Carol L. Brosgart to board of directors - Investing.com
Cocrystal Pharma Adds Veteran Leader to Board of Directors - TipRanks
Cocrystal Pharma (NASDAQ: COCP) names Carol L. Brosgart to its board - Stock Titan
Cocrystal Pharma strengthens board with antiviral expert appointment - TipRanks
Cocrystal Pharma appoints Carol Brosgart to board to bolster antiviral development - TradingView
Cocrystal Pharma (COCP) appoints antiviral veteran to board - Stock Titan
Cocrystal Pharma Appoints Antiviral Drug Expert Carol Brosgart to Board - citybiz.co
Cocrystal Pharma appoints Carol Brosgart to board of directors By Investing.com - Investing.com Nigeria
Cocrystal Pharma appoints Carol Brosgart to board of directors - Investing.com
Cocrystal Pharma Appoints Carol Brosgart, MD to its Board of Directors - The Manila Times
Cocrystal Pharma Appoints Carol Brosgart, M.D. to Board of Directors - Quiver Quantitative
A Gilead veteran joins Cocrystal’s board to guide antiviral drug development - Stock Titan
Cocrystal Pharma Q2 Results: EPS Loss Widens to $(0.23), Misses Estimate - scanx.trade
Cocrystal Pharma Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Cocrystal Pharma (COCP) flags going-concern risk amid Q2 2026 loss and $5M raise - Stock Titan
Cocrystal Pharma’s single oral drug for multiple viruses - drugdiscoverytrends.com
Cocrystal Pharma Inc expected to post a loss of 16 cents a shareEarnings Preview - TradingView
Cocrystal Pharma Inc (COCP) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Cocrystal Pharma (COCP) adds OPKO and insiders as major holders - Stock Titan
Cocrystal Pharma director Phillip Frost buys $9,816 in stock By Investing.com - Investing.com South Africa
Phillip Frost details 13.9% Cocrystal Pharma (COCP) stake in update - Stock Titan
Cocrystal Pharma director Phillip Frost buys $9,816 in stock - Investing.com
Cocrystal Pharma (COCP) insider buys 10,000 shares via trust - Stock Titan
Cocrystal Pharma, Inc. (COCP) insider-linked trust purchases 75,000 shares - Stock Titan
OPKO Health invests $5 million in Cocrystal Pharma By Investing.com - Investing.com
OPKO Health Boosts Stake in Cocrystal Pharma Financing - TipRanks
Cocrystal Pharma Raises $5 Million in Private Placement With OPKO Health at $0.9134/Share - TradingView
Cocrystal Pharma (NASDAQ: COCP) secures $5M investment from OPKO Health - Stock Titan
Cocrystal Pharma Announces $5 Million Private Placement with OPKO Health - globenewswire.com
Cocrystal Pharma, Inc. Revenue Breakdown – NASDAQ:COCP - TradingView
Cocrystal Pharma Inc (COCP) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Cocrystal Pharma, Inc. announced that it has received $5 million in funding from OPKO Health, Inc. - marketscreener.com
Cocrystal Pharma (COCP) Edges Higher Near Support ZoneFundamentals - vinanet.vn
Cocrystal Pharma Inc (COCP) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Cocrystal Pharma Inc (COCP) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
COCP|Cocrystal Pharma Inc|Price:0.919|Chg%:+0.019 - TradingKey
Cocrystal Pharma Inc Revenue Breakdown – FWB:8CC - TradingView
Cocrystal Pharma Inc (COCP) Institutional Confidence - TradingKey
Cocrystal Pharma Inc (COCP) Cash Flow - TradingKey
Cocrystal Pharma Inc (COCP) Income Statement - TradingKey
COCP|Cocrystal Pharma Inc|Price:1.110|Chg%:+0.030 - TradingKey
COCP|Cocrystal Pharma Inc|Price:0.900|Chg%:-0.020 - TradingKey
Cocrystal Pharma Inc Revenue Breakdown – LS:A3DWYX - TradingView
What's Driving the Micro-Cap Mania in SKYQ and COCP - Kavout | AI
Cocrystal Pharma Inc. (COCP) Stock Price | Live Quotes & Charts | NASDAQ - timothysykes.com
0.86%
0.31%
자본화:
|
볼륨(24시간):